These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 23895284)
21. Phospholipase D1 is an effector of Rheb in the mTOR pathway. Sun Y; Fang Y; Yoon MS; Zhang C; Roccio M; Zwartkruis FJ; Armstrong M; Brown HA; Chen J Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8286-91. PubMed ID: 18550814 [TBL] [Abstract][Full Text] [Related]
22. A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation. Dalle Pezze P; Sonntag AG; Thien A; Prentzell MT; Gödel M; Fischer S; Neumann-Haefelin E; Huber TB; Baumeister R; Shanley DP; Thedieck K Sci Signal; 2012 Mar; 5(217):ra25. PubMed ID: 22457331 [TBL] [Abstract][Full Text] [Related]
23. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Huang J; Wu S; Wu CL; Manning BD Cancer Res; 2009 Aug; 69(15):6107-14. PubMed ID: 19602587 [TBL] [Abstract][Full Text] [Related]
24. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. Carroll B; Maetzel D; Maddocks OD; Otten G; Ratcliff M; Smith GR; Dunlop EA; Passos JF; Davies OR; Jaenisch R; Tee AR; Sarkar S; Korolchuk VI Elife; 2016 Jan; 5():. PubMed ID: 26742086 [TBL] [Abstract][Full Text] [Related]
25. Phospholipase D regulates myogenic differentiation through the activation of both mTORC1 and mTORC2 complexes. Jaafar R; Zeiller C; Pirola L; Di Grazia A; Naro F; Vidal H; Lefai E; Némoz G J Biol Chem; 2011 Jun; 286(25):22609-21. PubMed ID: 21525000 [TBL] [Abstract][Full Text] [Related]
26. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells. Agarwal S; Bell CM; Rothbart SB; Moran RG J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395 [TBL] [Abstract][Full Text] [Related]
27. Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. Yoon MS; Sun Y; Arauz E; Jiang Y; Chen J J Biol Chem; 2011 Aug; 286(34):29568-74. PubMed ID: 21737445 [TBL] [Abstract][Full Text] [Related]
28. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421 [TBL] [Abstract][Full Text] [Related]
29. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation. Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN J Biol Chem; 2016 Mar; 291(12):6262-71. PubMed ID: 26755732 [TBL] [Abstract][Full Text] [Related]
30. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1). Xu L; Salloum D; Medlin PS; Saqcena M; Yellen P; Perrella B; Foster DA J Biol Chem; 2011 Jul; 286(29):25477-86. PubMed ID: 21622984 [TBL] [Abstract][Full Text] [Related]
31. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. Moore SF; Hunter RW; Hers I J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393 [TBL] [Abstract][Full Text] [Related]
32. TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression. Das F; Bera A; Ghosh-Choudhury N; Abboud HE; Kasinath BS; Choudhury GG PLoS One; 2014; 9(10):e109608. PubMed ID: 25333702 [TBL] [Abstract][Full Text] [Related]
33. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling. Miyazaki M; McCarthy JJ; Fedele MJ; Esser KA J Physiol; 2011 Apr; 589(Pt 7):1831-46. PubMed ID: 21300751 [TBL] [Abstract][Full Text] [Related]
34. FoxO1-AMPK-ULK1 Regulates Ethanol-Induced Autophagy in Muscle by Enhanced ATG14 Association with the BECN1-PIK3C3 Complex. Hong-Brown LQ; Brown CR; Navaratnarajah M; Lang CH Alcohol Clin Exp Res; 2017 May; 41(5):895-910. PubMed ID: 28299793 [TBL] [Abstract][Full Text] [Related]
37. Identification of rictor as a novel substrate of Polo-like kinase 1. Shao T; Liu X Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006 [TBL] [Abstract][Full Text] [Related]
38. Alcohol regulates eukaryotic elongation factor 2 phosphorylation via an AMP-activated protein kinase-dependent mechanism in C2C12 skeletal myocytes. Hong-Brown LQ; Brown CR; Huber DS; Lang CH J Biol Chem; 2007 Feb; 282(6):3702-12. PubMed ID: 17164244 [TBL] [Abstract][Full Text] [Related]
39. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells. Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838 [TBL] [Abstract][Full Text] [Related]
40. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function. Sun J; Liu Y; Moreno S; Baudry M; Bi X J Neurosci; 2015 Mar; 35(11):4706-18. PubMed ID: 25788687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]